C-MER Medical Holdings Limited (stock code: 03309) announced a Next Day Disclosure Return dated 27 November 2025. According to the filing, the number of issued ordinary shares (excluding treasury shares) changed from 1,238,112,870 to 1,237,992,870, while treasury shares increased from 17,448,000 to 17,568,000 on 27 November 2025. The total number of issued shares remained at 1,255,560,870.

On 27 November 2025, 120,000 shares were repurchased on the market at prices ranging between HKD 1.72 and HKD 1.74, totaling HKD 207,600. These repurchased shares were designated as treasury shares. The repurchase was conducted under a mandate dated 19 May 2025, authorizing the issuer to repurchase up to 125,556,087 shares, equivalent to 0.0097% of the issued shares as of the mandate date.

The filing also disclosed multiple share repurchases for cancellation from 12 July 2024 to 15 May 2025 that have not yet been canceled. The report confirms that the repurchases were in accordance with applicable exchange rules and that there have been no material changes to the previously submitted Explanatory Statement. A 30-day moratorium period applies for any new issue of shares or sale of treasury shares, through 27 December 2025, following the latest repurchase transaction.